| Methods | EA versus TA CVS. Women eligible were given the choice as to randomisation or to decide the method of prenatal diagnosis themselves. Randomisation was performed using sequentially numbered envelopes | |
| Participants | Women requesting prenatal diagnosis due to age related risk. 212 women were recruited, 115 agreed to be randomised; 70 chose EA and 25 CVS. 2 women did not participate because fetal death was diagnosed before any intervention | |
| Interventions | TA CVS was performed using a 20 G needle. AC was performed using a 22 G needle: 11 ml of amniotic fluid was aspirated, the first ml being discarded |
|
| Outcomes | Technical difficulties, abnormal karyotype, pregnancy complications, perinatal loss, neonatal complications, Dutch version of Denver Developmental Screening Test at 6-9 months | |
| Notes | Study stopped after 18 months following advice of the institutional ethical committee due to a higher incidence of fetal loss in the EA group | |
| Risk of bias | ||
| Item | Authors’ judgement | Description |
| Allocation concealment? | Yes | A - Adequate |